Bio-techs and FDA 510k stocks have been rocketing lately. And some of these are companies with lesser products and much, much more debt than CTGI. (NEPH)
All we need is a PR that says, "this company is not completely dead" and we'll fly past .25
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.